IP Library › Assignment 030703/0818
Patent Assignment
Reel/Frame 030703/0818

Assignment of Assignor's Interest

Recorded: 2013-06-27 Pages: 3
Assignor
ALNYLAM EUROPE AG
Executed: 2007-05-21
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property (1)
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE
Patent: 9,057,069 →
Application: 13/797,176 →
Publication: US 2013/0274311
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 18, 2013
From: BUMCROT, DAVID; SAH, DINAH WEN-YEE; TOUDJARSKA, IVANKA; GOLLOB, JARED
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 030238/0632 →
Corrective Assignment to Correct the Assignor Previously Recorded on Reel 030238 Frame 0632. Assignor(S) Hereby Confirms the Assignment. May 9, 2013
From: BUMCROT, DAVID
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 030390/0581 →
Assignment of Assignor's Interest Jun 27, 2013
From: TAN, PAMELA; VORNLOCHER, HANS-PETER; GEICK, ANKE
To: ALNYLAM EUROPE AG
Reel/Frame 030703/0811 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →